Press Releases

Date	Title
October 18, 2021	Angion to Present Multiple Posters at Kidney Week 2021	PDF Version
September 8, 2021	Angion Hosting Research & Development Day on ANG-3070 for the Treatment of Lung and Kidney Fibrosis	PDF Version
September 2, 2021	Angion to Participate in Upcoming September Investment Conferences	PDF Version
August 12, 2021	Angion Provides Corporate Update and Reports Second Quarter 2021 Financial Results	PDF Version
August 3, 2021	Angion Reports Positive Results from Phase 1 Healthy Volunteer Study for ANG-3070 and FDA Authorization to Initiate Phase 2 Trial in 2021	PDF Version
June 29, 2021	Angion Announces Results from the Phase 2 ALI-201 Study in Patients with COVID-19 Associated Pneumonia	PDF Version
May 17, 2021	Angion Provides Corporate Update and Reports First Quarter 2021 Financial Results	PDF Version
April 29, 2021	Angion and Vifor Pharma Announce Completion of Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury	PDF Version
March 30, 2021	Angion Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results	PDF Version
March 25, 2021	Angion Completes Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated Pneumonia	PDF Version